| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $13.57M | $13.07B | $12.55B | $11.13B | $9.47B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $10.66B | $10.53B | $10.16B | $8.62B | $6.86B |
| R&D | $536.62M | $496.74M | $510.99M | $491.48M | $434.85M |
| SG&A | $442.15M | $413.55M | $390.02M | $401.73M | $518.25M |
| Operating Income | – | – | – | – | – |
| Interest Expense | $28.47M | – | $53.11M | $146.31M | $73.85M |
| Tax Expense | $556.24M | $457.40M | $395.10M | $454.77M | $240.82M |
| Net Income | $2.54B | $2.38B | $2.34B | $2.27B | $2.51B |
| EPS (basic) | 2.0200 | 1.8500 | 1.7000 | 1.6000 | 1.7700 |
| EPS (diluted) | 1.9200 | 1.8100 | 1.6700 | 1.5600 | 1.6900 |
| Shares (diluted) | $1.33B | $1.32B | $1.40B | $1.45B | $1.48B |